Ken Griffin Ice Cure Medical Ltd. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ice Cure Medical Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 169,512 shares of ICCM stock, worth $144,085. This represents 0.0% of its overall portfolio holdings.
Number of Shares
169,512Holding current value
$144,085% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ICCM
# of Institutions
16Shares Held
364KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny66.4KShares$56,4400.0% of portfolio
-
Virtu Financial LLC New York, NY27.2KShares$23,1100.0% of portfolio
-
Geode Capital Management, LLC Boston, MA25.6KShares$21,7260.0% of portfolio
-
Two Sigma Investments, LP New York, NY21.3KShares$18,0660.0% of portfolio
-
Kingdom Financial Group Llc. Peoria, AZ17KShares$14,4500.01% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $31.3M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.